# Telix Pharmaceuticals Ltd: Form 6-K, filed Sep 1, 2026

- Company: [Telix Pharmaceuticals Ltd](/companies/tlx.md) (CIK 2007191)
- Form: 6-K
- Filed: 2026-09-01
- Accepted by EDGAR: Aug 31, 2026, 20:39 ET
- Period: 2026-09-01
- Accession: 0001628280-26-059684
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2007191/000162828026059684/telix-6kappointmentofdavid.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007191/000162828026059684/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007191/000162828026059684/telix-6kappointmentofdavid.htm

Filed Sep 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-059684. Last ingested by Listed: Oct 29, 2026, 16:54 ET. No prices; not investment advice.